Literature DB >> 21992131

Point mutations in myelodysplastic syndromes.

Frederik Damm, Michaela Fontenay, Olivier A Bernard.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21992131     DOI： 10.1056/NEJMc1108665

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.

Authors:  Virginie Chesnais; Aline Renneville; Andrea Toma; Jérôme Lambert; Marie Passet; Florent Dumont; Sylvie Chevret; Julie Lejeune; Anna Raimbault; Aspasia Stamatoullas; Christian Rose; Odile Beyne-Rauzy; Jacques Delaunay; Eric Solary; Pierre Fenaux; François Dreyfus; Claude Preudhomme; Olivier Kosmider; Michaela Fontenay
Journal:  Blood       Date:  2015-12-01       Impact factor: 22.113

Review 2.  Myeloid malignancies: mutations, models and management.

Authors:  Anne Murati; Mandy Brecqueville; Raynier Devillier; Marie-Joelle Mozziconacci; Véronique Gelsi-Boyer; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.